Rewriting the Histone Code of Breast Cancer Stem Cells

S AND MANUSCRIPTS MANUSCRIPTS Blancafort P, Juárez-Moreno K, Stolzenburg S, Beltran AS (2011) Engineering Transcription Factors in Breast Cancer Stem Cells. Breast Cancer Carcinogenesis, Cell Growth and Signalling Pathways ISBN 978-953-307-714-7, InTech, Available from: http://wwwintechopencom/articles/show/title/engineering-transcription-factors-inbreast-cancer-stem-cells. Rivenbark AG, Beltran AS, Yuan X, Rots MG, Strahl BD, Blancafort P. Epigenetic Reprogramming of Cancer Cells via Targeted DNA Methylation. Epigenetics (2012) Apr 1;7(4) Stolzenburg S, Rots MG, Beltran AS, Rivenbark AS, Yuan X, Strahl BS, Blancafort P (2012) Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Research. (2012) May 4 [Epub ahead of print]. Huang X, Narayanaswamy R, Fenn K, Szpakowski S, Sasaki C, Costa, J, Blancafort, P and Lizardi PM. Sequence-Specific Biosensors Report Drug-Induced Changes in Epigenetic Silencing in Living Cells. DNA Cell Biol. (2012) Feb 7. Blancafort P, Jin J, Frye S (2012). Writing and re-writing the epigenetic code of cancer cells: from engineered proteins to small molecules. Mol Pharmacology Minireview. In Press. ABSTRACTS/PRESENTATIONSS/PRESENTATIONS Stolzenburg, S, Beltran, AS, Strahl, BS & Blancafort P. Epigenetic targeting of Sox2 using engineered ZF remodeling enzymes. Selected for a presentation in the Era of Hope Meeting, Orlando, Florida, August 2011. Blancafort, P. Transcriptional regulation of breast cancer stem cell fate. American Society for Investigative Pathology. Breast Cancer Workshop. Washington, DC. April 13, 2011. Blancafort, P. Selection of Artificial Transcription Factors modulating breast cancer metastasis. Phage and Yeast Display Conference. Boston, MA. May 9-1